Journal
ONCOGENE
Volume 28, Issue 17, Pages 1916-1927Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2009.43
Keywords
Warts; hippo; yorkie; Drosophila; tumor; phosphorylation
Funding
- Howard Hughes Medical Institute
- NIH [1F32GM079817]
Ask authors/readers for more resources
The co-activator Yorkie (Yki) mediates transcriptional regulation effectedby the Drosophila Fat-Warts (Wts) Hippo (Hpo) pathways. Yki is inhibitedby Wts-mediated phosphorylation, and a Wts phosphorylation site at Ser168 has been identified. Here we identify two additional Wts phosphorylation sites on Yki, and examine the respective contribution of all three sites to Yki nuclear localization and activity. Our results show that although Ser168 is the most critical site, all three phosphorylation sites influence Yki localization and activity in vivo, and can be sites of regulation by Wts. Thus, investigations of the role of Yki and its mammalian homolog Yes-associated protein (YAP) in development and oncogenesis should include evaluations of additional sites. The WW domains of Yki are not required for its phosphorylation, but instead are positively required for its activity. We also identify two potential sites of phosphorylation by an unknown kinase, which could influence phosphorylation of Ser168 by Wts, suggesting that there are additional mechanisms for regulating Yki/YAP activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available